We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

dc.contributor.authorSabin, James E.
dc.contributor.authorMazor, Kathleen M.
dc.contributor.authorMeterko, Vanessa
dc.contributor.authorGoff, Sarah L.
dc.contributor.authorPlatt, Richard
dc.date2022-08-11T08:09:22.000
dc.date.accessioned2022-08-23T16:28:37Z
dc.date.available2022-08-23T16:28:37Z
dc.date.issued2008-10-25
dc.date.submitted2011-12-30
dc.identifier.citationHastings Cent Rep. 2008 Sep-Oct;38(5):39-48. <a href="http://www.jstor.org/stable/25165369">Link to article on publisher's website</a>
dc.identifier.issn0093-0334 (Linking)
dc.identifier.pmid18947140
dc.identifier.urihttp://hdl.handle.net/20.500.14038/37057
dc.description.abstract"Cluster randomized trials," in which groups of patients are randomly assigned to different therapeutic interventions, provide a powerful way of evaluating drugs. CRTs have not been widely used, in good part because of concerns about whether patients must give informed consent to participate in them. A better understanding of how CRTs fit into clinical practice resolves the concerns.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18947140&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.jstor.org/stable/25165369
dc.subject*Cluster Analysis
dc.subjectData Collection
dc.subjectHealth Facility Administrators
dc.subjectHumans
dc.subjectInformed Consent
dc.subjectPatient Satisfaction
dc.subjectRandomized Controlled Trials as Topic
dc.subjectHealth Services Research
dc.subjectPrimary Care
dc.titleComparing drug effectiveness at health plans: the ethics of cluster randomized trials
dc.typeJournal Article
dc.source.journaltitleThe Hastings Center report
dc.source.volume38
dc.source.issue5
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/meyers_pp/441
dc.identifier.contextkey2426097
html.description.abstract<p>"Cluster randomized trials," in which groups of patients are randomly assigned to different therapeutic interventions, provide a powerful way of evaluating drugs. CRTs have not been widely used, in good part because of concerns about whether patients must give informed consent to participate in them. A better understanding of how CRTs fit into clinical practice resolves the concerns.</p>
dc.identifier.submissionpathmeyers_pp/441
dc.contributor.departmentMeyers Primary Care Institute
dc.source.pages39-48


This item appears in the following Collection(s)

Show simple item record